Low concentrations of THC and 11-hydroxy-THC in serum samples are often claimed not to result from recent cannabis use. Prediction of time of exposure is difficult, especially if distinctive features of drug use could not be observed. Therefore, the aim of the study was to investigate the presence of THC and 11-hydroxy-THC in serum samples as well as to obtain preliminary data on the analyte profile for a time window of 24-48 hours after discontinuation of cannabis smoking. Serum samples from heavy (n = 12, > 1 joint/day), moderate (n = 11, < or = 1 joint/day) and light (n = 6, < 1 joint/week) smokers of cannabis were analyzed for THC, 11-hydroxy-THC and free THC-COOH by GC/MS as well as for glucuronidated THC-COOH by LC/MS-MS. The blood samples were collected 24-48 hours after abstaining from cannabis use. Additionally, 8 specimens were obtained from persons after discontinuation of the drug for more than 48 hours. During collection of the blood samples, distinctive effects due to drug use could not be observed. For heavy users of cannabis, THC was detectable in 8 samples, and in 5 cases both biologically active compounds, THC and 11-hydroxy-THC, were present (1.3-6.4 ng THC/mL serum, 0.5-2.4 ng 11-hydroxy-THC/mL serum). Among moderate users, in 1 sample 1.8 ng THC/mL serum and 1.3 ng 11-hydroxy-THC/mL serum were determined, and another sample was tested positive with low concentrations close to the limit of detection. In serum samples of light users both analytes could not be detected, indicating that in those persons a positive finding of THC and 11-hydroxy-THC may rather result from recent consumption than from cannabis use 1 or 2 days prior to blood sampling. The concentrations of THC-COOH and its glucuronide covered a wide range in all groups of cannabis users. However, there was a trend to higher concentrations in heavy users compared to moderate users, and the mean concentration was smaller in light smokers than in moderate smokers. Overall, the findings indicated that data from pharmacokinetic studies should be supplemented by data obtained from "real-life" samples.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Fatty acid binding protein 7 plays an important modulatory sex-dependent role on brain endocannabinoid levels and THC metabolism.
PLoS One
December 2024
Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, United States of America.
Article Synopsis
- FABP7 is a protein found in the brain that may help transport cannabinoids like THC, but its role in the endocannabinoid system is not fully understood.
- In a study using mice lacking FABP7, researchers measured THC and its metabolite 11-OH-THC levels after THC inhalation, finding that females with FABP7 deletion had lower levels of 11-OH-THC compared to those with the protein.
- The study also revealed that FABP7 influences endocannabinoid levels, showing females with FABP7 deletion had decreased levels of anandamide and increased levels of 2-AG, indicating a sex-specific role in THC metabolism and endocannabinoid regulation.
Are Δ-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?
Int J Mol Sci
November 2024
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, USA.
Article Synopsis
- Δ-Tetrahydrocannabinol (THC) is the main psychoactive ingredient in cannabis, and its usage among pregnant individuals is rising, leading to concerns about fetal exposure.
- Research indicates that fetal THC exposure is significantly lower than maternal levels due to a specific placental transporter that actively reduces THC transfer to the fetus, although the exact identity of this transporter remains unknown.
- In lab studies, it was discovered that THC and its metabolite THC-COOH acted as substrates for certain liver transporters but were not inhibitors, highlighting the complexity of THC metabolism and transport in the body.
Sex Differences in the Neural and Behavioral Effects of Acute High-Dose Edible Cannabis Consumption in Rats.
J Pharmacol Exp Ther
October 2024
Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada (R.Q.A., H.K., M.A.T., A.H., Y.G., R.J., J.Y.K.); Avicanna Inc., Toronto, Canada (K.U.); and Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada (J.Y.K.)
The consumption of Δ-tetrahydrocannabinol (THC)- or cannabis-containing edibles has increased in recent years; however, the behavioral and neural circuit effects of such consumption remain unknown, especially in the context of ingestion of higher doses resulting in cannabis intoxication. We examined the neural and behavioral effects of acute high-dose edible cannabis consumption (AHDECC). Sprague-Dawley rats (six males, seven females) were implanted with electrodes in the prefrontal cortex (PFC), dorsal hippocampus (dHipp), cingulate cortex (Cg), and nucleus accumbens (NAc).
View Article and Find Full Text PDFQuantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID cases.
J Anal Toxicol
May 2024
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, 4800 SW 35th Drive, Gainesville, FL 32610, USA.
Hexahydrocannabinol (HHC) was first reported in the EU in May 2022. HHC has three chiral carbon atoms, but only (6aR,9R,10aR)-HHC (9R-HHC) and (6aR,9S,10aR)-HHC (9S-HHC) have been encountered in HHC products. The aim of this study was to develop and validate a method for the quantitative analysis of 9R-HHC, 9S-HHC, 11-OH-9R-HHC, 9R-HHC-COOH, 9S-HHC-COOH and 8-OH-9R-HHC.
View Article and Find Full Text PDFPostmortem redistribution of cannabinoids: Statistical analysis of a novel dataset and meta-analysis.
Forensic Sci Int
December 2023
Laboratoire de sciences judiciaires et de médecine légale, Department of Toxicology, 1701 Parthenais Street, Montréal, Québec H2K 3S7, Canada.
The assessment of human postmortem concentrations of Δ-THC (THC) and its metabolites, 11-nor-9-carboxy-THC (THCCOOH) and 11-hydroxy-THC (11-OH-THC), is routinely performed in forensic toxicology laboratories. However, the literature on cannabinoids postmortem redistribution (PMR) is scarce and highlights their complex postmortem changes. This study aims to investigate the postmortem behavior of THC and its metabolites in order to provide practitioners with potential indicators of PMR.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!